Strategic fit ChromoTek specializes in alpaca Nanobodies and custom Nanobody services, positioning them as a niche supplier for innovative antibody tools that can complement Proteintech Group’s broader catalog and open cross-sell opportunities for specialized research workflows.

Digital enablement With recent investments in AI and digital pathology collaborations through Proteintech, there is a potential to upsell Nanobody-based solutions and digital-ready reagents to clients adopting AI-assisted workflows and digital pathology platforms.

Global collaboration An established presence in Germany and the US, plus Proteintech’s international reach, provides a pathway to co-market and co-sell Nanobody reagents to Western markets and biotech customers seeking validated, high-quality nanobody tools.

Education unlock Award-winning educational resources and ongoing workshops indicate an opportunity to bundle Nanobody training kits or dedicated antibodies for education-focused accounts, universities, and early-career researchers needing hands-on Nanobody guidance.

SMB growth With a lean team and a revenue profile in the sub-million range, ChromoTek can pursue scalable, high-margin services such as custom Nanobody development and QA/validation partnerships, aligning with Proteintech’s platform to expand sales into mid-market biotech startups.